Sen. Wyden probes 'secret, sweetheart' deal between Pfizer, Trump

Pfizer made waves when it decided to defer price hikes until the Trump Administration can implement its drug pricing blueprint or until the end of the year, whichever comes sooner. Now, a top Democrat wants to know more about the deal and the conversation that led to the decision.